DK0936923T3 - Undertrykkelse af TNFalpha og IL-12 ved terapi - Google Patents

Undertrykkelse af TNFalpha og IL-12 ved terapi

Info

Publication number
DK0936923T3
DK0936923T3 DK97912367T DK97912367T DK0936923T3 DK 0936923 T3 DK0936923 T3 DK 0936923T3 DK 97912367 T DK97912367 T DK 97912367T DK 97912367 T DK97912367 T DK 97912367T DK 0936923 T3 DK0936923 T3 DK 0936923T3
Authority
DK
Denmark
Prior art keywords
tnf
tnfalpha
suppression
therapy
disclosed
Prior art date
Application number
DK97912367T
Other languages
Danish (da)
English (en)
Inventor
Marc Feldmann
Anne-Marie Aline Miche Malfait
Debra Maree Butler
Fionula Mary Brennan
Ravinder Nath Maini
Original Assignee
Kennedy Inst Of Rheumatology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kennedy Inst Of Rheumatology filed Critical Kennedy Inst Of Rheumatology
Application granted granted Critical
Publication of DK0936923T3 publication Critical patent/DK0936923T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97912367T 1996-11-15 1997-11-17 Undertrykkelse af TNFalpha og IL-12 ved terapi DK0936923T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74997996A 1996-11-15 1996-11-15
PCT/GB1997/003151 WO1998022137A1 (fr) 1996-11-15 1997-11-17 SUPPRESSION DU FNTα ET DE IL-12 EN THERAPIE

Publications (1)

Publication Number Publication Date
DK0936923T3 true DK0936923T3 (da) 2004-04-26

Family

ID=25016019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97912367T DK0936923T3 (da) 1996-11-15 1997-11-17 Undertrykkelse af TNFalpha og IL-12 ved terapi

Country Status (9)

Country Link
US (1) US20070178099A1 (fr)
EP (1) EP0936923B1 (fr)
AT (1) ATE256476T1 (fr)
AU (1) AU4959997A (fr)
DE (1) DE69726878T2 (fr)
DK (1) DK0936923T3 (fr)
ES (1) ES2213209T3 (fr)
PT (1) PT936923E (fr)
WO (1) WO1998022137A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706264B1 (en) 1994-03-14 2004-03-16 Genetics Institute, Llc Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y
US7220717B2 (en) 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
US7704944B2 (en) 1997-08-14 2010-04-27 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
IL121860A0 (en) 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
WO2000041547A2 (fr) * 1999-01-13 2000-07-20 The Rockefeller University Procedes permettant de favoriser ou de renforcer la production d'interleukine-12 par administration de thalidomide
US7883704B2 (en) 1999-03-25 2011-02-08 Abbott Gmbh & Co. Kg Methods for inhibiting the activity of the P40 subunit of human IL-12
US6914128B1 (en) 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
KR20140094647A (ko) * 1999-03-25 2014-07-30 아비에 도이치란트 게엠베하 운트 콤파니 카게 사람 ｉｌ-12에 결합하는 사람 항체 및 이의 제조방법
ES2311483T3 (es) * 1999-12-14 2009-02-16 Genentech, Inc. Anatagonista del tnf-alfa y antagonista del lfa-1 para el tratamiento de la artritis reumatoide.
ME00546B (me) * 2000-02-21 2011-10-10 Serono Lab Korišćenje inhibitora il-18
ATE526020T1 (de) 2000-08-10 2011-10-15 Cold Spring Harbor Lab Gesteigertes kognitives training
US20040224316A1 (en) 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
US7868015B2 (en) 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
US6881407B2 (en) * 2000-08-11 2005-04-19 Ashok Amin Method for treating hepatitis
EP1199074A1 (fr) * 2000-09-15 2002-04-24 Warner-Lambert Company Composition pharmaceutique pour la prévention ou le traitement de maladies associées à un excès de production d' IL-12
EP1188438A1 (fr) * 2000-09-15 2002-03-20 Warner-Lambert Company Compositions pharmaceutiques pour la prévention ou le traitement de maladies associées à un excès de production de l' IL-12
GB0128138D0 (en) * 2001-11-23 2002-01-16 King S College London Pharmaceutical use
US20030161828A1 (en) * 2002-02-19 2003-08-28 Abbott Gmbh & Co. Kg Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
US7101978B2 (en) 2003-01-08 2006-09-05 Applied Molecular Evolution TNF-α binding molecules
EP1651266B1 (fr) * 2003-07-25 2010-03-03 Laboratorios Silanes, S.A. de C.V. Administration de fragments d'anticorps f(ab')2 anti-tnf-alpha
US7435799B2 (en) 2004-01-08 2008-10-14 Applied Molecular Evolution TNF-α binding molecules
CN104524567A (zh) 2007-01-16 2015-04-22 阿布维公司 用于治疗银屑病的方法
MX2009010361A (es) 2007-03-29 2009-10-16 Abbott Lab Anticuerpos il-12 anti-humanos cristalinos.
TW201513883A (zh) 2008-03-18 2015-04-16 Abbvie Inc 治療牛皮癬的方法
CN104974251A (zh) * 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
MX2011004198A (es) * 2008-10-20 2011-05-24 Abbott Lab Anticerpos que unen a il-12 y metodos para purificar los mismos.
NZ592094A (en) * 2008-10-20 2013-01-25 Abbott Lab Antibodies that bind to il-18 and methods of purifying the same
SG10201702922VA (en) * 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
KR20140048229A (ko) 2009-09-14 2014-04-23 애브비 인코포레이티드 건선을 치료하는 방법
GB201013975D0 (en) 2010-08-20 2010-10-06 Imp Innovations Ltd Method of treating desease
US8394593B2 (en) * 2010-02-12 2013-03-12 Trudeau Institute Use of an IL-12 receptor splice variant and molecular assay to quantify expression thereof
US8877212B2 (en) 2011-02-07 2014-11-04 Trudeau Institute Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
DE07012626T1 (de) * 1991-03-18 2010-01-21 New York University Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor
US5698195A (en) * 1991-03-18 1997-12-16 New York University Medical Center Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies
DE69312077T2 (de) * 1992-10-08 1997-10-30 Kennedy Inst Of Rheumatology Behandlung von autoimmun- und entzundungskrankheiten
US5536657A (en) * 1993-07-19 1996-07-16 Hoffmann-La Roche Inc. Recombinant DNA encoding human receptor for interleukin-12
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
DE69637599D1 (de) * 1995-08-01 2008-08-21 Hoffmann La Roche Rezeptoren für das humane Interleukin-12

Also Published As

Publication number Publication date
US20070178099A1 (en) 2007-08-02
WO1998022137A1 (fr) 1998-05-28
EP0936923A1 (fr) 1999-08-25
ES2213209T3 (es) 2004-08-16
DE69726878T2 (de) 2004-10-21
DE69726878D1 (de) 2004-01-29
ATE256476T1 (de) 2004-01-15
PT936923E (pt) 2004-04-30
AU4959997A (en) 1998-06-10
EP0936923B1 (fr) 2003-12-17

Similar Documents

Publication Publication Date Title
DK0936923T3 (da) Undertrykkelse af TNFalpha og IL-12 ved terapi
DE69125025T2 (de) Verfahren zur homo- oder copolymerisation von ethen
EP0620409A3 (fr) Simulation électro-optique de cible et fond.
HK1022440A1 (en) Combination therapy using a tnf binding protein for treating tnf-mediated diseases
DE68927671T2 (de) Produkte zur Behandlung des Endotoxin -Schocks bei einem Säugetier
NO901112D0 (no) Adaptiv terskelholdingsteknikk.
IT8125097A0 (it) Procedimento e dispositivo perl'introduzione di almeno un inserto in fascicoli.
DK0760010T3 (da) Fremgangsmåder til screening for Crohn's sygdom under anvendelse af TNF-mikrosatellit-alleler
NO905391D0 (no) Ammunisjonsenhet ned adaptivt anslagsroer.
DE3852389T2 (de) Rissformungsverhütung in implantierten Prothesen.
DE3878567D1 (de) Vinylmonomer enthaltende haertbare siliconzusammensetzungen.
MX9702789A (es) Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos.
IT8819515A0 (it) Copolimero acrilico idrossilato.
IT8424113A0 (it) Metodo per la preparazione di copolimeri aggraffati per polimerizzazione in emulsione.
DE59104832D1 (de) Perfluoralkylgruppen enthaltende Pfropfcopolymerisate.
FR2736538B3 (fr) Cage intersomatique pour rachis lombaire
GR3021421T3 (en) Compositions for use in a method for treating a human suffering from multiple sclerosis
ZA989036B (en) Methods and compositions for treating rheumatoid arthritis.
EP0642333A4 (fr) Procede et composition pour le traitement de troubles associes a un dysfonctionnement immunologique.
HUP0002304A2 (hu) Állatok májából kivonható fehérjék alkalmazása tumor nekrózis faktor túltermelődéssel járó kóros állapotok kezelésére használható gyógyászati készítmények előállítására
ITMO930022A1 (it) Impianto di smistamento, formazione e allontanamento di pile, di piastrelle ceramiche multiformato.
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
NO983220D0 (no) Sammensetninger og fremgangsmater for ö administrere Borrelia Burgdorferi-antigener
IT8125518A0 (it) Procedimento per la polimerizzazione e copolimerizzazione in sospensione di cloruro di vinile.
IT9003692A0 (it) Dispositivo per l' assemblaggio di pannelli di mobili in genere.